Robinson, Claire M.
University of Toronto
3 papers on CoChatORCID 0000-0002-6126-3889
Most cited papers
- Verified
NRAS Status Determines Sensitivity to SHP2 Inhibitor Combination Therapies Targeting the RAS–MAPK Pathway in Neuroblastoma
Valencia-Sama, I., Ladumor, Y., Kee, L., Adderley, T., Christopher, G., Robinson, C. M., Kano, Y., Ohh, M., & Irwin, M. S. (2020) · Cancer Research
Neuroblastoma Research and TreatmentsProtein Tyrosine Phosphatases
Cited by 62
- Verified
The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors
Gebregiworgis, T., Kano, Y., St-Germain, J., Radulovich, N., Udaskin, M. L., Mentes, A., Huang, R., Poon, B. P. K., He, W., Valencia-Sama, I., et al. (2021) · Nature Communications
Protein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase Signaling
Cited by 49
- Verified
Consequences of VHL Loss on Global DNA Methylome
Robinson, C. M., Lefebvre, F., Poon, B. P., Bousard, A., Fan, X., Lathrop, M., Tost, J., Kim, W. Y., Riazalhosseini, Y., & Ohh, M. (2018) · Scientific Reports
Epigenetics and DNA MethylationCancer, Hypoxia, and Metabolism
Cited by 21
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free